EMILY CANNON: Open Payments
NPI 1720319130 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,522 in 13 payments from 7 companies in 2025. Trend: 2023 $580 · 2024 $994 · 2025 $1,522
Food & beverage: $1,171Travel & lodging: $351
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 5 | $811 |
| Abbott Laboratories | 2 | $321 |
| AstraZeneca Pharmaceuticals LP | 2 | $172 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Boston Scientific Corporation | 1 | $57 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: Barostim Neo System, CARDIOMEMS, CAMZYOS, General - Therapies, LOKELMA, LEQVIO, JARDIANCE.
Industry payments across TX — which companies pay providers there.
